Tess Egginton

Innovent Biologics has announced a collaboration and exclusive license agreement with Roche to advance the development of IBI3009, a novel delta-like ligand 3 (DLL3)-targeted...

Immedica Pharma, a global rare disease company, is set to acquire Marinus Pharmaceuticals, a pharmaceutical company committed to improving the lives of patients with...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine sotatercept (Winrevair) to treat pulmonary arterial hypertension (PAH). Sotatercept is used, in...